Log In
BCIQ
Print this Print this
 

VK0214 (formerly LG0956965)

Also known as: Thyroid receptor beta agonist

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionLiver-selective thyroid hormone receptor beta agonist
Molecular Target Thyroid hormone receptor beta
Mechanism of ActionThyroid hormone receptor beta agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationLeukodystrophy
Indication DetailsTreat X-linked adrenoleukodystrophy (ALD)
Regulatory Designation
PartnerViking Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,531.5M

0

$1,500.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/22/2014

$1,531.5M

0

$1,500.0M

Get a free BioCentury trial today